March 04, 2021 1 min read

CFA Asks for Pre-Market Safety Review, Accurate Labeling on Cell-Cultured Seafood Products

Default News Placeholder 6

CFA submitted the following comments in response to the U.S. Food and Drug Administration’s (“FDA”) request for comments regarding cell-cultured or “lab grown” food products derived from seafood.  The comments acknowledge that cell-cultured products, if made affordable and shown to be safe, could help to address important challenges in the food system. However, accurate and accessible labeling, as well as a comprehensive and transparent pre-market safety review, will serve a critical role in establishing consumer trust.

Testimonies & Comments

Default News Placeholder 6
Consumer Groups Oppose Addition of Segway Language Until Hearing on Safety Issues
Default News Placeholder 6
CFA Opposes McConnell Medical Malpractice Amendment
Default News Placeholder 6
Letter to President Bush on HHS Study of Medical Malpractice Insurance Rates
Default News Placeholder 6
Testimony of Travis Plunkett Regarding Medical Malpractice Insurance Rates